Low-Cost Nanobodies from Alpacas are Highly Potent Inhibitors of SARS-CoV-2
Researchers at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany, engineered mini-antibodies, called nanobodies, against SARS-CoV-2. The team’s nanobodies are stable up to 95 degrees Celsius (203 F) and are cheaper and less ...
Source: Medgadget - Category: Medical Devices Authors: Conn Hastings Tags: Medicine Nanomedicine Public Health Source Type: blogs
More News: Chemistry | Clinical Trials | Coronavirus | COVID-19 | Germany Health | International Medicine & Public Health | Medical Devices | Nanotechnology | Respiratory Medicine | SARS | Study | Vaccines | Veterinary Vaccinations